Articles tagged with 'Consumer Health' | Bayer

Newsroom Bayer (Consumer Health)

2023
December
07,
2023
| 08:29 AM Europe/Amsterdam
London, UK, and Basel, Switzerland, December 7, 2023 – Salus Optima, a leading provider in AI-enabled digital health and wellness solutions, and the Consumer Health division of Bayer have launched a strategic partnership to empower people on their he...
Read more
November
28,
2023
| 08:29 AM Europe/Amsterdam
Advancing precision health and accelerating access to novel epigenetic and multi-omics at-home biomarker tests to empower consumers on their aging journey
Read more
November
08,
2023
| 07:29 AM Europe/Amsterdam
Group sales of 10.342 billion euros (Fx & portfolio adj. minus 0.2 percent) / EBITDA before special items: 1.685 billion euros (minus 31.3 percent) / Sales stable at Crop Science and Pharmaceuticals and up slightly at Consumer Health (Fx & portfolio ...
Read more
August
08,
2023
| 07:29 AM Europe/Amsterdam
Group sales fall by 8.2 percent (Fx & portfolio adj.) to 11.044 billion euros / EBITDA before special items: 2.527 billion euros (minus 24.5 percent) / Crop Science business down significantly, mainly due to sharp decline in glyphosate volumes and pr...
Read more
May
31,
2023
| 08:59 AM Europe/Amsterdam
Basel, Switzerland, May 31, 2023 – The Consumer Health Division of Bayer has launched a business unit focused on developing new Precision Health products across its range of everyday health categories. Bayer will prioritize developing products that e...
Read more
May
11,
2023
| 07:29 AM Europe/Amsterdam
Group sales stable at 14.389 billion euros (Fx & portfolio adj. minus 1.1 percent)o   Accelerated normalization in glyphosate business – good price dynamics in other Crop Science unitso   New Pharmaceuticals products deliver strong growth – headwinds...
Read more
March
07,
2023
| 08:59 AM Europe/Amsterdam
Basel, Switzerland, March 7, 2023 — A first-of-its-kind collaboration in the consumer health industry is developing a platform aimed at reducing or replacing animal testing using “organ-on-chip” (OoC) technology and interactive computational software...
Read more
February
28,
2023
| 07:30 AM Europe/Amsterdam
Group sales increase 8.7 percent (Fx & portfolio adj.) to 50.739 billion euros / EBITDA before special items rises 20.9 percent to 13.513 billion euros, largely driven by exceptionally strong performance at Crop Science / Pharmaceuticals increases sa...
Read more
February
23,
2023
| 08:29 AM Europe/Amsterdam
The Nutrient Gap Initiative, aiming to improve access to essential nutrients for 50 million people by 2030, expands its scope to include both supplementation and food
Read more
2022
November
08,
2022
| 10:00 AM Europe/Amsterdam
Chairman of the Board of Management / Chief Financial Officer
Read more
November
08,
2022
| 07:30 AM Europe/Amsterdam
Group sales increase by 5.7 percent (Fx & portfolio adj.) to 11.281 billion euros  / EBITDA before special items rises by 17.3 percent to 2.451 billion euros / Crop Science achieves strong sales gains – sales also up at Pharmaceuticals and Consumer H...
Read more
August
02,
2022
| 08:45 AM Europe/Amsterdam
Empowering consumers to take more control over their own health means ensuring they have the knowledge and trust that products are safe and will work as described  / The Principles of Science-Led Self-Care paper forms a blueprint for the industry...
Read more
May
10,
2022
| 07:30 AM Europe/Amsterdam
Group sales grow by 14.3 percent (Fx & portfolio adj.) to 14.639 billion euros / EBITDA before special items increases by 27.5 percent to 5.251 billion euros / Substantial sales and earnings growth at Crop Science and Consumer Health / Sales up sligh...
Read more
April
29,
2022
| 10:00 AM Europe/Amsterdam
Chairman of the Board of Management
Read more
April
29,
2022
| 10:00 AM Europe/Amsterdam
Chairman of the Supervisory Board of Bayer AG
Read more
March
01,
2022
| 10:00 AM Europe/Amsterdam
Werner Baumann, Chairman of the Board of Management (CEO) of Bayer AG:Good morning everybody! On behalf of the entire Board of Management, I would like to wish you all a very warm welcome to our virtual Financial News Conference. I am delighted that ...
Read more
March
01,
2022
| 07:30 AM Europe/Amsterdam
Group sales increase by 8.9 percent (Fx & portfolio adj.) to 44.081 billion euros / EBITDA before special items declines by 2.5 percent to 11.179 billion euros - inflation-related increase in costs and negative currency effects largely offset / Crop ...
Read more
February
02,
2022
| 11:00 AM Europe/Amsterdam
Basel, Switzerland, February 2, 2022 - Today Bayer announced Dr. Ricardo Salazar Hernández as the new Global Medical Affairs function with responsibilities over medical insights, claims and evidence strategies and generation, and health care professi...
Read more
2021
December
01,
2021
| 14:00 PM Europe/Amsterdam
The Consumer Health division accelerates the execution of its sustainability program and strikes partnership for collective action across the self care industry
Read more
November
09,
2021
| 10:00 AM Europe/Amsterdam
Chairman of the Board of Management / Chief Financial Officer
Read more
November
09,
2021
| 07:30 AM Europe/Amsterdam
Group sales rise by 14.3 percent (Fx & portfolio adj.) to 9.781 billion euros / EBITDA before special items increases by 16.4 percent to 2.089 billion euros / Crop Science reports strong increase in sales and earnings / Pharmaceuticals and Consumer H...
Read more
August
05,
2021
| 07:31 AM Europe/Amsterdam
Group sales increase by 12.9 percent (Fx & portfolio adj.) to 10.854 billion euros - double-digit percentage growth (Fx & portfolio adj.) at all divisions / EBITDA before special items declines by 10.6 percent to 2.577 billion euros, burdened by curr...
Read more
May
27,
2021
| 13:15 PM Europe/Amsterdam
Ada Health combines medical knowledge with powerful AI to revolutionize possibilities for personal health for patients globally / Investment to support advancement of Ada’s symptom assessment and care navigation platform...
Read more
May
12,
2021
| 07:30 AM Europe/Amsterdam
Good operational performance - sales and earnings negatively impacted by currency of 938 million euros and 337 million euros / Group sales up by 2.8 percent (Fx & portfolio adj.) to 12.328 billion euros / EBITDA before special items down 6.2 percent ...
Read more
April
27,
2021
| 10:00 AM Europe/Amsterdam
Stable operational development in fiscal 2020 despite the COVID-19 pandemic / Dividend of 2.00 euros per share proposed / Early indications of a successful start to 2021 / Board of Management regards Bayer as better positioned than almost any other c...
Read more
April
27,
2021
| 10:00 AM Europe/Amsterdam
Chairman of the Supervisory Board of Bayer AG
Read more
April
27,
2021
| 10:00 AM Europe/Amsterdam
Chairman of the Board of Management
Read more
February
25,
2021
| 10:00 AM Europe/Amsterdam
Chairman of the Board of Management / Chief Financial Officer
Read more
February
25,
2021
| 07:30 AM Europe/Amsterdam
Group sales at 41.400 billion euros, impacted by negative currency effects of 1.941 billion euros (Fx & portfolio adj. plus 0.6 percent) / EBITDA before special items level with prior year at 11.461 billion euros (minus 0.1 percent) - currency effect...
Read more
February
02,
2021
| 14:00 PM Europe/Amsterdam
Primary Focus will be on Most Vulnerable - Pregnant Women and Children in Underserved Communities
Read more